Home > Income Statement > AUROBINDO PHARMA

AUROBINDO PHARMA
Revenue

    Back to Income Statement
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹24,855 Cr₹23,455 Cr₹24,775 Cr₹23,099 Cr₹19,564 Cr

What is the latest Revenue of AUROBINDO PHARMA ?

The latest Revenue ratio of AUROBINDO PHARMA is ₹24,855 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹24,855 Cr
Mar2023₹23,455 Cr
Mar2022₹24,775 Cr
Mar2021₹23,099 Cr
Mar2020₹19,564 Cr

How is Revenue of AUROBINDO PHARMA Trending?

Years Revenue % Change
Mar2024 ₹24,855 Cr
5.97
Mar2023 ₹23,455 Cr
-5.32
Mar2022 ₹24,775 Cr
7.26
Mar2021 ₹23,099 Cr
18.07
Mar2020 ₹19,564 Cr -

Compare Revenue of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹81,001.3 Cr -0.1% -6.4% 63.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹438,418.0 Cr -1.2% -4.7% 58.1% Stock Analytics
DIVIS LABORATORIES ₹157,680.0 Cr 0.8% 7.1% 73.4% Stock Analytics
CIPLA ₹128,755.0 Cr 2.7% -2.8% 32.8% Stock Analytics
DR REDDYS LABORATORIES ₹108,720.0 Cr 2.3% -2.2% 20.9% Stock Analytics
ZYDUS LIFESCIENCES ₹100,120.0 Cr -0.7% -5.6% 69.2% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-0.1%

-6.4%

63.5%

SENSEX

0.6%

-0.8%

25.4%


You may also like the below Video Courses